ADHERENCE Patrick Desmet HIV / Therapycounselor. 1. What is adherence and why is it important? 2. The factors that influence adherence? 3. How can we.

Slides:



Advertisements
Similar presentations
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Advertisements

ARV Nurse Training, Africaid, 2004 ARV Nurse Training Programme Marcus McGilvray & Nicola Willis Adherence.
Section 22.4 Protecting Yourself From HIV and AIDS Objectives
Adherence Works In 1998, knew missed doses led to resistant virus. Since 1998, studies have demonstrated that adherence leads to lower viral loads, decreased.
Adherence in the new era of HAART A call for community pharmacists Blake Max, PharmD University of Illinois at Chicago Ruth Rothstein CORE Center Cook.
Lecture 3: Health Psychology and Physical Illnesses I (Part 2)
When Less is More: Transmission of Drug-Resistant HIV in Canada STIRRHS Conference Montreal, Quebec June 3, 2006.
Experience under the TAP: Determinants and experience with adherence in Burkina Faso Hospital and Community Sites in Burkina Faso Pascal NIAMBA, Cecile.
Promoting Adherence in Children. What are the challenges faced by children that interfere with ART adherence? B ased on your knowledge and experience,
ADHERENCE Patrick Desmet HIV / Therapycounselor.
Integrating Evidence-Based Practice Into QI to Improve Patient Outcomes in HIV: Viral Load Suppression Victoria Lieb, ACRN, MPH; Carla Rossi, MD; Jaime.
Adherence, Resistance and Antiretroviral Therapy
Incorporating HIV Prevention into the Medical Care of Persons Living with HIV Ask ∙ Screen ∙ Intervene Developed by: The National Network of STD/HIV Prevention.
Adherence to ART Bannet Ndyanabangi Copenhagen, February 2006.
Unit 10 HIV Care and ART: A Course for Physicians
Clinical Training: Medication Reconciliation
+ Module Four: Patient/Family Education and Self-Management At the end of this module, the participant will be able to: Describe three learning needs of.
Introduction to ARV therapy
1 Lecture 9: Adherence in ARV Therapy delivered by Dr. Ndwapi Ndwapi, BHP KITSO AIDS Training Program.
Why are we learning this? How scientific knowledge (pharmacology, therapeutics) and clinical skills (measuring blood pressure, glucoses, drug information)
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Future ART options for HIV-infected children exposed to maternal HAART Lee Kleynhans Experts Roundtable June 2008.
JNB/05 HIV/AIDS treatment - challenges in a remote rural area of Tanzania. Johan N. Bruun Department of Infectious Diseases Ullevål University Hospital.
1 Assessing and Improving ARV Adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
Medication Adherence The following module is designed as a basic overview of medication adherence for providers of healthcare, particularly those in a.
1 Advantages and risks for a child to be exposed to the triple prophylaxis during pregnancy and breastfeeding What is the best for the child ? Pr C. Courpotin.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
Enhanced Patient-Safety Intervention To Optimize Medication Education (EPITOME) Carl Sirio, MD Professor Critical Care Medicine, Medicine and Pharmacy.
Medication Adherence: What Can We Do to Help Patients Stick to Therapy Lois Eldred, DrPH, MPH Special Projects of National Significance HIV/AIDS Bureau,
M. Ekstrand 1,2,3, A. Shet 2,4, S. Chandy 4, G. Singh 4, R. Shamsundar 4, V. Madhavan 5, S. Saravanan 5, N. Kumarasamy 5 1 University of California, San.
Health systems barriers to adherence in antiretroviral treatment programmes in rural South Africa Dr Brian van Wyk School of Public Health University of.
Immigration Removal Centres and HIV Clinical Care Jane Anderson Homerton University Hospital NHS Foundation Trust.
Module 2: Learning Objectives
Providing Treatment, Restoring Hope Secondary Prevention as part of HIV Clinical Care Martine Etienne, MPH, DrPH University of Maryland School of Medicine.
Adherence Preparing to start ARVs Dr. Kevin M Harvey MBBS, MPH (UWI), Dip. ID (Lon.) Treatment care and support 2006.
Assessing Your Clients for Adherence: A Real World Approach Sharon Mannheimer, MD Harlem Hospital Center Treatment Adherence Network Meeting February 27,
Drug Adherence and Strategies for Compliance Assist. Prof. Dr. Memet IŞIK Ataturk University Medical Faculty Department of Family Medicine
1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.
Adherence to HAART. Adherence Summary Adherence is the Achilles Heel of HAART Adherence requires education, a shared negotiation, & the optimal regimen.
1 Pediatric ARV adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Major Changes to the HHS Adult and Adolescent HIV Treatment Guidelines: April 2015 Brian R. Wood, MD.
Using Multiple Data Sources to Understand Variable Interventions Bruce E. Landon, M.D., M.B.A. Harvard Medical School AcademyHealth Annual Research Meeting.
Aiming for Ease: The Importance of Regimen Convenience In Antiretroviral Therapy Jointly sponsored by Postgraduate Institute for Medicine and Clinical.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
POSITIVE PREVENTION YOUNG PEOPLE’S TRAINING BY; HADIA HAWA.
Effective HIV & SRH Responses Among Sex Workers and other Key Populations Module 3: Engaging Key Populations with HIV and SRH Services.
Improving Patients Retention in Antiretroviral Treatment Programs: The experience of ARV Programs in Côte d’Ivoire Eugène MESSOU, MD, PhD CePReF- Aconda.
Learning objectives Review HIV treatment goals
Learning objectives Define HIV treatment goals
Vancouver, British Columbia, Canada
Jessica Haberer, MD, MS July 24, 2017
Pharmacokinetics: HIV Drugs
Jeopardy Game Hosted by PHDP Jamaica MODULE 4 Treatment Literacy.
Paediatric HIV and Adherence
Introduction to Clinical Pharmacy
Adherence to ART: Why is it so important? 1.
VL patient support: General education at different levels
Section 22.4 Protecting Yourself From HIV and AIDS Objectives
T . P. MHEMBERE: BSc Pharm Hons (Zim), MPH (UK)
Section 22.4 Protecting Yourself From HIV and AIDS Objectives
Experiences & outcomes of group psychotherapy as an antiretroviral adherence support intervention among young people failing ART at Newlands Clinic, Harare,
Pharmaceutical care plans Ola Ali Nassr
Presentation transcript:

ADHERENCE Patrick Desmet HIV / Therapycounselor

1. What is adherence and why is it important? 2. The factors that influence adherence? 3. How can we improve adherence? D V D - Testimonies

“ …Stick to the times, having the right amount of drugs at all times in the system. Otherwise the virus will breakthrough and starts multiplying again…” “…Never missed a dose during my pregnancy…” “…Taking your medication as directed, to have a sufficient dose that will have the desired effect…” “…The ability to take your drugs to an extent that they will work…”

The medication adherence is the ability of the patient to be involved in: choosing, starting, managing and maintaining a given therapeutic combination regimen to control viral replication and improve the immune function. Jane M.Simoni Ph D What is Adherence ?

“ …Stick to the times, having the right amount of drugs at all times in the system. Otherwise the virus will breakthrough and starts multiplying again….” “ …Taking your medication as directed, to have a sufficient dose that will have the desired effect…..”

Electronic Event Monitoring (MEMS ® ) UZ Leuven Fabienne Dobbels

“….Otherwise the virus will breakthrough and starts multiplying again” Adapted from: Paterson DL et al. Ann Intern Med 2000;133: Mean adherence rate Relationship of adherence (measured by MEMS® 81 patients / doses / 6 months of FU ) to virologic success >95%90%-95%80%-90%70%-80%<70% Patients Reaching Undetectable HIV RNA LOQ 400 (%) P = <0.001 Greatest danger zone for developing resistance

Log concentration (ng/mL) day 1day 2day 3day 4day 5 dose miss EC 50 Even 48 hours post-dose, plasma levels remain above EC50 Half life: >12 hours Examples: EFV, TDF, ddI, Atazanavir “ …Taking your medication as directed, to have a sufficient dose that will have the desired effect….”

ADHERENCE vs. PHARMACY REFILLS Hogg et al.7th CROI 2000/abs73. Objective : HIV-disease progression / AIDS vs. Adherence Methods : 950 patients ARV naive (85% PI and 15%NNRTI) + 2NRTI Median follow-up 13 months Pharmacy based records, refills Conclusion For each 10% decline in adherence 16% increase in mortality

“ …It’s difficult when I need to go to an event, wedding, party, …. Anytime where you are exposed taking your drugs…” Disclosure “… Absolutely terrible, it was worse going to therapy than having my AIDS diagnosis. For me it was the slippery slope downhill…” Anxiety

“…I forgot my medication for days, because I was living a very hard life. My mind was thinking of many other things than medication….” “….It was the most difficult thing I had to do in my life…” “… I was never been sick since my diagnosis it was very difficult to convince myself to start up therapy…” Motivation

MOTIVATION ESTABLISH : READINESS COMMITMENT ASYMPTOMATIC vs.SYMPTOMATIC MOTIVATION Preventive Measures ART-SE Distress ART Stop = SE Relief Reinforce the Necessity OI-status, Pill Burden, Drug-drug Interactions LONG-TERM TREATMENT

“…Somethimes I rush to work, because there is an important meeting I need to go to and I forgot to take my medication…” “…Yes sometimes I forgot them because I was not at home and I was in a rush…” Anticipation

Why do Patients Miss Doses? Adapted from: Gifford AL et al. JAIDS 2000; 23: Reasons given for missing antiretroviral doses (structured questionnaire) possible interventions simplify dosing schedule decrease pill burden other % n= Too busy/simply forgot Away from home Change in daily routine Felt depressed/overwhelmed Took drug holiday/medication break Ran out of medication Too many pills Worried about becoming 'immune' Felt drug was too toxic Wanted to avoid side effects Didn't want others to notice Reminder of HIV infection Confused about dosage direction Didn't think it was improving health To make it last longer Were told the medicine is no good

ADHERENCE

Denial HIV- status Negative beliefs (negative arv history partner) Fear of Short or Longterm - Side Effects Lack off trust towards Health-Care team PATIENT FACTORS ARV = ongoing reminder of HIV status

HEALTHCARE FACTORS STAFF TRAINING INSUFFICIENT STAFF & SPACE for COUNSELLING CONFIDENTIALITY (reception, waiting rooms, personalised interviews vs. Multidisciplinary team) POOR ORGANIZATION OF DAILY CARE AUTHORITARIAN AND JUDGEMENTAL ATTITUDE CONFLICTING PATIENT-INFORMATION (EDUCATION)

Cultural and Socio-economic Status Drug (speed, ecstasy…) and Alcohol use Fear of Disclosure : ARV > trigger HIV-Status Welfare status: housing, financial support… Stigmatisation : cultural / religious beliefs

TREATMENT FACTORS CONCOMITANT /ALTERNATIVE MEDICINE DRUG TOXICITIES: SHORT AND LONGTERM SE COMPLEX REGIMEN / PILL BURDEN DOSING FREQUENCY / DRUG INTERACTIONS DIETARY RESTRICTIONS LOGISTICAL : APPROVALS / AVAILABILITY OF DRUGS ACCUMULATIVE TREATMENT CHANGES

“…It’s incredible important to get the right regimen for the right person, it’s really about looking at the individual patient….” “…As a patient I need much more information…” “…You need to prepare the patient properly…” Fit the ARV’s into the lifestyle

PATIENT EMPOWERMENT BASIC KNOWLEDGE SKILLS & MOTIVATION HEALTH BELIEFS & CULTURAL / SOCIO-ECONOMIC STATUS

Flow Chart Counseling New HIV+  TRUST  KNOWLEDGE  LIFESTYLE  Potential ADHERENCE and ARV-BARRIERS OPTIMISING HAART PEOPLES LIVES = VARIABLE BEHAVIOR IMPACT from ENVIRONMENT  SOCIAL FACTORS  NEW DIAGNOSES DYNAMIC MONITORING 3 STEP APPROACH = a stepwise informationflow

Counseltopics Sec.Prevention: Safe sex,… HIV basics AIDS vs. HIV Disclosure CD4 & VL-interpretation before and during therapy Life expectansy Evaluation 2 ARV proposals  Lifestyle:Diet, work, co-medication…  Potential Adherence and Therapy barriers  Social status check cf. social nurses!  Drug specific Side effects: short & longterm Initiate Dummy Run ARV support : community (sensoa) Adherence: timing, dosing, food, anticipation Adherence vs. Resistance 2 visits

Counseltopics Drugplanning: optimizing drugintake, identify ARV- reminders, ARV-storage, food recommendations…. Patient rehearses drugplanning and potential SE Drug specific SEffects Supportive Tools Counseltopics Telephone call patient / counselor Anticipate SEffects cf Dr. Adherence check: = Timing, dosing, diet,anticipation, ARV_storage. Reasons for non-adherence Initiation Haart and follow- up READINESS COMMITMENT

Pillbox and reminder system UZ Leuven

Vibrating alarms, watches, cell-phone alarm, SMS

ADHERENCE COUNSELING MULTIDISCIPLINARY TEAM EFFORT NEGOTIATION INFORMATION EDUCATION BEFORE, DURING and AFTER START of ART